Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Assets: 2011-2025

Historic Return on Assets for Fennec Pharmaceuticals (FENC) over the last 14 years, with Sep 2025 value amounting to -0.14%.

  • Fennec Pharmaceuticals' Return on Assets fell 12.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -0.01% for FY2024, which is 58.00% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Return on Assets of -0.14% as of Q3 2025, which was up 45.82% from -0.25% recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Return on Assets high stood at 0.07% for Q1 2024, and its period low was -1.44% during Q2 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.25% (2025), whereas its average is -0.46%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by 47bps in 2023, then surged by 148bps in 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Return on Assets (Quarterly) stood at -0.61% in 2021, then declined by 30bps to -0.94% in 2022, then increased by 27bps to -0.67% in 2023, then soared by 67bps to 0.00% in 2024, then fell by 12bps to -0.14% in 2025.
  • Its Return on Assets was -0.14% in Q3 2025, compared to -0.25% in Q2 2025 and -0.30% in Q1 2025.